The role involves driving the adoption of Ferring's first-in-class intravesical gene therapy for non-muscle invasive bladder cancer across New England.
Base: $180,000 to $220,000; Bonus/Equity: Annual incentive compensation based on individual and geography/company performance; Benefits: Comprehensive healthcare, 401k match, paid parental leave, vacation accrual
Must-have
Nice-to-have
Not specified